SS-31

Clinical Trials

Elamipretide (MTP-131)

Aliases
Elamipretide, MTP-131, Bendavia
Administration
Subcutaneous injection, IV infusion (clinical)

Research and regulatory

Development stage

Phase II/III active — heart failure with preserved ejection fraction (HFpEF).

Legal and regulatory

Investigational New Drug (IND); Phase II/III clinical trials active.

Side effects

Injection site reactions; well-tolerated in trials